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Abstract
Background
The debate whether "asymptomatic hyperuricemia" should be treated is still ongoing. The
objective of this cross-sectional study was to analyze whether hyperuricema in the elderly is
associated with joint pain.
Methods and findings
Participants in the population-based AGES-Reykjavik Study (males 2195, females 2975,
mean age 76(6)) answered standardized questions about joint pain. In addition they
recorded intermittent hand joint pain by marking a diagram of the hand. In males, no associ-
ation was found between hyperuricemia and pain. Females however, showed a positive
association between hyperuricemia and joint pain at many sites. After adjustment for age,
BMI and hand osteoarthritis however, only intermittent hand joint pain (OR 1.30(1.07–1.58),
p = 0.008) and intermittent pain in�10 hand joints (OR 1.75(1.32–2.31), p<0.001) remained
significant. The best model for describing the relationship between serum uric acid levels
(SUA) and intermittent hand joint pain in�10 joints was non-linear with a cut-off at
372 μmol/L. The attributable surplus number of symptomatic females with SUA�372 μmol/
L was approximately 2.0% of the study population for those reporting pain in�10 hand
joints. Next after having severe hand osteoarthritis, SUA�372 was an independent predic-
tive factor of intermittent pain in�10 hand joints. Intermittent hand joint pain was also an
independent risk factor for worse general health description.
Conclusion
Results from this population based study indicate that hyperuricemia in elderly females may
be a rather frequent cause of intermittent hand joint pain, often in many joints. The most
likely explanation relates to low-grade urate crystal induced inflammation. Our data do not
allow for assessment of the severity of symptoms or whether they merit specific treatment,
but intermittent hand joint pain was an independent predictor of worse general health.
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These findings may be an important contribution to the debate on whether hyperuricemia
should be treated.
Introduction
Hyperuricemia is part of a complex metabolic condition that is associated with age, gender,
nutritional status including obesity and alcohol use, genetics, renal function and drugs, partic-
ularly diuretics. It´s prevalence appears to be rising globally. In the absence of gouty arthritis,
hyperuricemia is considered to be asymptomatic as indicated by the commonly used term
asymptomatic hyperuricemia[1,2].
In recent years, a number of studies have indicated that hyperuricemia may be deleterious
to renal and cardiovascular health, but due to the complex interrelations between hyperurice-
mia and several other risk factors, there is still a lack of agreement whether it is the hyperurice-
mia itself that is harmful or it´s associated metabolic and life-style factors[3–6]. A recent
review by Li et al. concludes that convincing evidence of a clear role of serum uric acid (SUA)
level only exists for gout and nephrolithiasis[7]. There is also a lack of intervention studies in
asymptomatic hyperuricemia, although some studies indicate a beneficial effect of uric acid
lowering therapy on renal function both in patients with and without renal disease [8,9] and a
reduced risk of developing hypertension in patients with type 2 diabetes [10]. In rheumatology,
hyperuricemia and symptomatic gout appear to be a part of a spectrum, with crystal deposition
and synovitis in joints sometimes evident even in the absence of clinical gout [11–13]. A recent
NHANES study also indicates that hyperuricemia is associated with symptomatic knee osteo-
arthritis, most apparent in non-obese patients [14].
Due to the complexity of hyperuricemia and its association with other diseases and disease
associated factors, large studies with extensive biochemical and health related information are
necessary. The AGES-Reykjavik Study, a large population based study of elderly people in
Reykjavik fulfills these criteria[15]. We have previously reported on osteoarthritis and pain in
this population[16,17].
In the present study, we analyzed possible associations between serum uric acid levels and
reported joint pain at different joint sites.
Methods
The AGES-Reykjavik Study (Age, Gene/Environment Susceptibility—Reykjavik Study) is a
population based study of elderly individuals from the 40 year long Reykjavik Study. Partici-
pants were aged between 66 and 96 and randomly recruited between 2002 and 2006. Written
informed consent was obtained from all participants. Details of the investigations are
described in the study´s baseline article[15]. The study is approved by the Icelandic National
Bioethics Committee, (VSN: 00–063) and the Data Protection Authority.
The current study population is identical with our previous studies of osteoarthritis [16,17]
with exclusion of individuals with evidence of inflammatory arthritis on hand photographs or
having hand photographs that were unreadable with regard to hand osteoarthritis. This left a
study group of 5170 subjects (2195 males and 2975 females, mean age 76(6)). Due to the
marked gender differences in serum uric acid levels, males and females were analyzed sepa-
rately. Hyperuricemia was defined as serum uric levels above the normal laboratory limits of
400 μmol/L in females and 480 μmol/L in males. Laboratory analyses were done using a Hita-
chi 912 analyzer (Roche Diagnostics) with reagents from Roche Diagnostics and following the
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manufacturer’s instructions. Reference values from The Nordic Reference Interval Project
2000 were used [18].
Study variables were acquired through laboratory tests, questionnaires and photographs, all
taken at initial visit. Data about previous myocardial infarction were based on questionnaires,
hospital records, the Icelandic Heart association registry and ECG. Similarly, previous coro-
nary events also included CHD, PTCA and CABG.
Questionnaire information
The pain questions were as follows:
Have you ever had pain, aching or stiffness in either knee, lasting for at least one month?
Have you ever had pain in or around either hip joint, including the buttock, groin or either
side of the upper thigh, lasting at least one month?
Have you ever had pain lasting at least one month in the joints of your hands or wrist?
Have you ever had pain lasting for at least one month in your feet toes or ankles?
For each of the four questions above there was another starting by “In the past 12 months”
followed by the same question.
In addition, participants filled out a diagram of both hands asking about sometimes joint
pain and if yes, mark which particular joints (S1 and S2 Figs). The 20 alternatives were CMC1,
IP1, DIP 2–5 and PIP 2–5 on both sides. In the article, those who gave a positive answer are
referred to a having intermittent hand joint pain.
The question about general health was: In general, how would you rate your health? Excel-
lent, Very good, Good, Fair or Poor. This variable was dichotomized into two parts as general
health excellent, very good or good vs worse than good (fair or poor).
Education level was in four categories, corresponding to: primary school, secondary school,
college and university. This variable was dichotomized into two parts by college education or
higher.
The presence and severity of hand osteoarthritis was read from high quality digital photo-
graphs resulting in an aggregate score of 0–4 (HOASCORE) as previously described. Individu-
als with scores of 4 were classified as having severe hand OA[19].
The metabolic syndrome was defined according to the WHO definition criteria[20].
Data from the AGES study are available through collaboration (AGES_data_request@h-
jarta.is) under a data usage agreement with the IHA with an IRB approval in accordance with
the informed consent.
Statistics
Descriptive statistics are presented for participants with and without hyperuricemia according
to laboratory normal values using t-test, chi square, and binary logistic regression. In the pain
analysis age and BMI were used as covariates except for hand pain where the presence of severe
hand OA was also used as a covariate.
On analysis of the relationship between SUA and pain the main outcome variables was
joint pain treated as a binary variable: sometimes pain reported in 10 or more joints vs. the
opposite. The outcome was analysed using binary logistic regression, with logit link, where the
main predictor variable was serum uric acid. We used age (continuous), BMI (continuous),
and severe hand OA (yes/no) as covariates.
We compared six types of models, each with a different representation of the main predic-
tor variable: linear, spline, step, step with segment, segment, and hinge. Here linear representa-
tion refers to the classical logistic regression model where serum uric acid is linearly associated
with the logit of pain. The spline model was fitted using generalized additive models (GAM)
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for logistic regression using a spline function[21]. The models of type: step, step with segment,
segment, and hinge were fitted using threshold regression model estimation. Threshold regres-
sion models are a diverse set of non-regular regression models that all depend on change
points or thresholds[22]. Standard error estimate for the cutoff value was generated using the
bootstrap method with 1000 replications.
The models were compared using Nagelkerke’s R2, the AIC or the Akaike information cri-
terion, and the AUC or the area under the receiver operating characteristics (ROC) curve. The
contribution of the model variables to the prediction of pain was quantified by reporting the
chi-square value of the likelihood ratio statistic from the multivariable logistic regression
model.
The statistical analysis was performed using R version 3.4.2[23].
Results
The characteristics of the study population in relation to the presence of hyperuricemia are
shown in Table 1. The mean(SD) SUA in males was 382(91) and in females 332(93) μmol/L.
UA levels showed (SUA) highly significant correlations with many of the variables in the
table, associating positively with age, weight, BMI, abdominal circumference, fasting glucose,
hs-CRP, triglycerides, creatinine, HbA1c, use of antihypertensive medications, the metabolic
syndrome, history of previous cardiac events, worse general health and the use of thiazides,
loop diuretics, ACE inhibitors and hypoglycemics. A negative association was seen with s-
HDL(mmol/l) and education. No association was seen between SUA and severe hand
osteoarthritis.
Hyperuricemia in males was not associated with reported pain. Unadjusted, females with
hyperuricemia had significant association with reported pain at all four sites. On adjustment
age and BMI were used, but based on previous findings of the association of hand osteoarthri-
tis and hand pain [17], hand symptoms were also adjusted for the presence of severe hand oste-
oarthritis(HOA). The adjustment for severe HOA had negligible effect on association for other
sites. After adjustment, only intermittent hand symptoms remained significant (Table 2).
None of the other laboratory markers were associated with joint pain. The metabolic syn-
drome had an association with knee pain that vanished after adjustment for age, gender and
BMI. Although hs-CRP was higher in hyperuricemic females, it showed no association with
intermittent pain.
The association between uric acid levels and intermittent hand pain in females was consis-
tent and clear, being highly significant for each and every of the 20 joints reported and stron-
gest in those individuals reporting intermittent pain in many (�10) hand joints.
The relationship between SUA levels and intermittent hand pain
We examined the relationship between SUA and intermittent hand joint pain in�10 hand
joints by applying 6 different models of threshold regression. Uric acid was a predictor for
pain in all 6 model types. The model with the highest R2, lowest AIC and highest AUC was the
step model. This model was therefore chosen as the best fitting model (Fig 1).
The best fitting model for having intermittent pain in�10 joints was the non-linear step
model indicating a cut-off for SUA at 372μmol/L (SE = 28). Below this level 8.9% had symp-
toms vs 15.8% with higher levels. This relationship is shown in Fig 1. The likelihood ratio sta-
tistics to quantify the strength of the association of the variables in the step model were: 0.3 for
BMI (p-value 0.58); 16.9 for age (p-value <0.0001); 25.9 for Uric acid (as a threshold variable
at the value 372) (p-value<0.0001); and 106.8 for severe hand OA (p-value<0.0001). Model
comparison is shown in Table 3.
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Attributable risk calculation indicated that the surplus number of females with SUA
�372 μmol/L compared with those with SUA lower than 372μmol/L reporting intermittent
pain in�10 joints was 60 out of 2975 females or approximately 2% of the female study
Table 1. Baseline characteristics in relation to hyperuricemia.
MALES FEMALES
Normouricemic Hyperuricemic Normouricemic Hyperuricemic
(�480μmol/L) (>480μmol/L) (�400μmol/L) (>400μmol/L)
n mean(SD) n mean(SD) p-value n mean(SD) n mean(SD) p-value
General t-test t-test
Age 1908 76.4(5.3) 287 76.8(5.5) 0.31 2371 76.1(5.6) 604 77.5(7.7) <0.001
Height(cm) 1906 175.5(6.1) 287 175.3(6.3) 0.52 2370 161.0(5.8) 603 160.3(5.7) 0.008
Weight(kg) 1907 82.1(12.9) 287 88.3(14.5) <0.001 2370 69.1(12.8) 603 75.5(13.5) <0.001
BMI(kg/m 2) 1906 26.6(3.7) 287 28.7(4.3) <0.001 2370 26.6(4.6) 603 29.4(4.9) <0.001
Abdominal circumference(cm) 1907 101.6(10.2) 287 107.2(11.1) <0.001 2369 98.0(12.5) 604 99.4(12.9) <0.001
Laboratory serum concentrations
Fasting glucose(mmo/l) 1908 5.9(1.2) 287 6.1(1.1) 0.004 2371 5.6(1.1) 604 5.9(1.1) <0.001
Cholesterol(mmol/l) 1908 5.2(1.1) 287 5.2(1.0) 0.40 2371 6.0(1.1) 604 5.9(1.2) 0.63
HDL(mmol/l) 1908 1.4(0.4) 287 1.3(0.4) <0.001 2371 1.8(0.4) 604 1.6(0.4) <0.001
hs-CRP(mg/l) 1908 3.6(6.7) 286 4.1(5.3) 0.17 2370 3.4(6.2) 604 4.6(5.2) <0.001
Triglycerides(mmol/l) 1908 1,1(0.6) 287 1.5(0.9) <0.001 2371 1.1(0.5) 604 1.5(0.8) <0.001
Creatinin(μmol/l) 1908 97.9(24.3) 287 124.4(43.0) <0.001 2371 78.1(20.5) 604 98.1(28.4) <0.001
LDL(mmol/l) 1907 3.2(1.0) 287 3.3(0.9) 0.73 2370 3.7(1.0) 602 3.7(1.1) 0.89
HbA1c(%) 1763 5.7(0.6) 266 5.7(0.5) 0.22 2179 5.7(0.5) 552 5.8(0.5) <0.001
History percent n percent x2 n percent n percent x2
Using antihypertensives 1908 58 287 91 <0.001 2371 57 604 92 <0.001
Past myocardial infarction 1895 17 285 22 0.07 2347 7 594 12 <0.001
Past coronary event 1895 32 285 39 0.03 2347 12 594 22 <0.001
Metabolic syndrome(WHO) 1895 21 285 48 <0.001 2350 15 363 39 <0.001
Severe hand OA (photo) 1908 8 287 9 0.81 2371 16 604 18 0.30
General health not good 1902 28 286 31 0.19 2368 34 603 42 <0.001
College education 1904 30 286 35 0.15 2366 24 603 19 0.006
Ever smoker 1906 72 287 70 0.62 2368 47 604 49 0.41
Medication use
Thiazides 1908 18 287 49 <0.001 2371 29 604 63 <0.001
Loop diuretics 1693 8 277 26 <0.001 2162 5 592 20 <0.001
ACE-inhibitors 1693 17 277 31 <0.001 2162 10 592 18 <0.001
Hypoglycemics 1693 9 277 11 0.26 2162 4 592 7 0.001
Allopurinol 1908 5 287 6 0.56 2371 2 604 2 0.63
Pain
Knee pain 1904 30 286 34 0.19 2368 40 603 43 0.16
Knee pain past 12 months 1907 19 287 22 0.30 2371 30 604 35 0.02
Hip pain 1902 18 285 22 0.14 2358 29 602 34 0.02
Hip pain past 12 months 1908 10 287 13 0.06 2371 18 604 22 0.03
Hand pain 1902 11 286 9 0.35 2366 26 603 29 0.15
Hand pain past 12 months 1908 6 287 5 0.89 2369 17 604 19 0.51
Foot pain 1895 17 285 16 1.00 2361 26 600 32 0.006
Foot pain past 12 months 1908 11 287 10 0.54 2371 20 604 26 0.002
https://doi.org/10.1371/journal.pone.0221474.t001
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Table 2. The association between hyperuricemia and pain at different joint sites.
Males (n = 2195, upper normal 480 μmol/L)
Unadjusted(Mantel-Haenszel) Adjusted(Binary logistic regression with age, BMI�
(and hand OA severity)��)
%pos OR(95%CI) p-value OR(95%CI) p-value
Knee pain 31 1.20(0.92–1.56) 0.2 0.98(0.98–1.02) 0.9 �
Knee pain past 12months 20 1.18(0.87–1.60) 0.3 0.96(0.70–1.31) 0.8 �
Hip pain 18 1.27(0.94–1.72) 0.1 1.22(0.88–1.64) 0.3 �
Hip pain past 12months 10 1.44(0.99–2.09) 0.1 1.38(0.94–2.02) 0.1 �
Foot pain 17 0.99(0.71–1.40) 1.0 0.92(0.65–1.29) 0.6 �
Foot pain past 12months 11 0.87(0.57–1.31) 0.5 0.78(0.51–1.18) 0.2 �
Hand pain 11 0.79(0.51–1.23) 0.3 0.74(0.48–1.16) 0.2 ��
hand pain past 12months 6 0.93(0.53–1.62) 0.8 0.86(0.49–1.51) 0.6 ��
Intermittent hand joint pain 13 1.08(0.76–1.54) 0.7 1.03(0.71–1.48) 0.9 ��
Intermittent hand joint pain�10 joints 2 1.25(0.52–3.02) 0.6 1.03(0.42–2.57) 0.9 ��
Females (n = 2975,upper normal 400 μmol/L) Adjusted(Binary logistic regression with age, BMI�
(and hand OA severity)��)
% pos OR(95%CI) p-value OR(95%CI) p-value
Knee pain 41 1.14(0.95–1.37) 0.2 0.88(0.73–1.07) 0.2 �
Knee pain past 12months 31 1.27(1.05–1.53) 0.01 0.98(0.80–1.20) 0.8 �
Hip pain 30 1.13(1.03–1.51) 0.02 1.11(0.91–1.35) 0.3 �
Hip pain past 12months 19 1,28(1.03–1.59) 0.03 1.15(0.97–1.00) 0.2 �
Foot pain 27 1.32(1.09–1.60) 0.005 1.19(0.97–1.45) 0.1 �
Foot pain past 12months 21 1.40(1.13–1.72) 0.002 1.24(1.00–1.55) 0.05 �
Hand pain 26 1.16(0.95–1.42) 0.1 1.19(0.96–1.47) 0.1 ��
Hand pain past 12months 18 1.08(0.86–1.36) 0.5 1.07(0.84–1.37) 0.6 ��
Intermittent hand joint pain 38 1.37(1.14–1.64) 0.001 1.30(1.07–1.58) 0.008 ��
Intermittent hand joint pain�10 joints 11 1.72(1.33–2.22) <0.001 1.75(1.32–2.31) <0.001 ��
https://doi.org/10.1371/journal.pone.0221474.t002
Fig 1. This figure where the dots represent deciles of SUA illustrates the best fitting threshold regression STEP
model for the relationship between SUA levels and the proportion of females with intermittent hand pain in�10
hand joints by each decile. It also demonstrates the estimated cut-off at SUA�372 μmol/L.
https://doi.org/10.1371/journal.pone.0221474.g001
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population. The surplus number was even higher for those reporting any intermittent pain
(n = 85 or 2.9% of the study population).
SUA and hand osteoarthritis as predictors of intermittent hand pain
In an attempt to estimate the relative contributions of hyperuricemia and hand osteoarthritis
to intermittent hand pain in females we did a predictive power analysis for having intermittent
pain in�10 hand joints. Adding joint pain at other sites to the model did not affect the results
which are shown in Fig 2.
Intermittent hand pain and reported general health
In an attempt to ascertain the severity and significance of intermittent hand joint pain we did
an analysis of reported general health quality (dichotomized into excellent, very good and
good vs fair or bad) and intermittent pain in females. Binary logistic regression revealed a
highly significant negative associations between having intermittent pain in�10 hand joints
and reported health quality. Regression analysis indicated an effect size (OR 3.0(2.4–3.8)) at
least comparable to that of having pain lasting a month or more in feet (OR 2.5(2.1–3.0), knee
(OR 1.9(1.6–2.2)) or hip (OR 2.1(1.8–2.5)
Discussion
In this large population based study of elderly Icelanders, we found a highly significant associa-
tion between hyperuricemia and intermittent hand joint pain in females, but no association in
males. Even after adjustment for hand osteoarthritis severity, which is the strongest predictor
of hand pain, SUA levels emerged as an independent predictive factor. These associations were
particularly strong in those reporting intermittent pain in many hand joints. The association
between SUA and intermittent pain in�10 hand joints was non-linear with a calculated cut-
off at�372 μmol/L. Intermittent hand joint pain was in itself a highly significant predictor of
worse general health with an effect at least comparable with having had foot, knee or hip pain
lasting a month or more.
The most likely explanation for the episodic pain is inflammation due to urate crystal depo-
sition. Dual energy CT imaging has demonstrated the occasional presence of urate deposits in
joints and tendons, even in the absence of clinical gout[11]. A number of external factors such
as usage, microtrauma and temperature as well as dehydration have been implicated in induc-
ing gouty episodes[24]. Increased urate concentration appears to be the universal key factor in
igniting the inflammatory response although other proteins and factors may act as promoters
[25]. Interpreting the current findings, it appears that these metabolic and external circum-
stances may be present in the hand joints of elderly females. The non-linear association with a
threshold level supports the concept of biochemical saturation reaching a threshold for
Table 3. Comparison of model fit statistics: Nagelkerke‘s Rs, Akaike Information Criterion (AIC), and the Area Under the Curve (AUC).
AUC 95% CI
Model R2 AIC AUC Lower Upper
Linear 0.086 1923 0.68 0.65 0.71
GAM 0.089 1923 0.68 0.65 0.71
Step 0.093 1913 0.69 0.66 0.72
Step Segment 0.093 1917 0.69 0.66 0.72
Hinge 0.086 1923 0.68 0.65 0.71
Segmented 0.088 1923 0.67 0.64 0.71
https://doi.org/10.1371/journal.pone.0221474.t003
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crystallization and inflammatory episodes with pain. Regarding the current findings, it is
important to realize that information about intermittent pain in our study was only available
for the hand joints. It is likely that the traditional pain questions requiring pain episodes to last
at least a month are insensitive in detecting hyperuricemia associated joint pain. The hand
findings in the current study may thus apply to other joint sites. There have been a few studies
that indicate that hyperuricemia is associated with foot and knee pain even in the absence of
clinical gout[13,26], and the work of Stewart and Dalbeth on hyperuricemia related foot pain
show considerable similarities with the current study findings[11,13]. In renal patients, hyper-
uricemia also seems to be an independent predictor of musculoskeletal symptoms[27].
Clinicians occasionally observe patients describing diffuse episodes of pain in multiple
joints in the hands. Descriptions such as “hot or burning pain in my hands” are heard. It is
interesting to speculate whether such episodes may be the hyperuricemia associated
Fig 2. SUA levels and severe hand osteoarthritis as predictors of intermittent hand joint pain in�10 hand joints. The figure shows the ROC curves for 4 different
models. Model 0 with just age and BMI, model 1 adding only SUA�372 μmol/L as a threshold variable, model 2 adding only severe hand OA, and model 3 adding both
variables. The area under the ROC curves were respectively: 0.58, 0.60, 0.66, 0.69. The difference in area under the curve between model 2 and model 3 was statistically
significant p = 0.005. In other words, adding SUA�372 μmol/L as a threshold variable to a model with age, BMI, and severe hand OA significantly improves the capacity
of the model to diagnose pain.
https://doi.org/10.1371/journal.pone.0221474.g002
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“sometimes pain” phenomenon we are describing in this study. Predisposing factors might
include usage, microtrauma, exposure to cold and fluctuations in hydration status which is
more common in the elderly [28]. Why the association between SUA and intermittent pain
applies solely to females and not males is unexplained, but males report less pain at all sites.
Although uric acid induced inflammation may be the most logical explanation for intermit-
tent pain in many hand joints, other explanations cannot be ruled out. The female population
with SUA�372 μmol/L is older, less educated, heavier, has more evidence of a metabolic dis-
order, is using more antihypertensive medications, is more likely to have had cardiac events
and reports worse general health compared to those with SUA<372 μmol/L. Any or all of
these factors as well as possible alcohol consumption may contribute to hand pain through
psychological mechanisms or increased pain sensitization. If this were the case however, one
would expect a more general pain effect on other joint sites and also a higher prevalence of
long lasting pain, not being limited to intermittent pain in the hands. These same factors may
of course have bearing on the worse general health reported in the group with intermittent
hand pain.
A limitation of this study is difficulty in finding other cohorts where these findings could be
replicated. Unfortunately, the question about “sometimes pain” is non-traditional and we have
not been able to locate a cohort where these results could be corroborated. Another limitation
is the cross sectional nature of the data and our inability to assess the clinical significance of
the hyperuricemia associated hand pain and whether it is of sufficient magnitude to merit spe-
cific interventions. Intermittent hand pain seems to be an independent predictor of general
poor health, but once more the complexity of hyperuricemia associated conditions limits the
scope for conclusions on this matter. The old age of the study population also limits conclu-
sions with regard to the applicability of these results to other age categories, it may be limited
to elderly females only, possible reasons being age-related changes in hand tissues and fluctua-
tions in hydration status. The cut-off of SUA<372 μmol/L calculated in the current study may
also vary between populations, depending on a number of other factors including obesity [14].
The current findings appear to indicate a hitherto undescribed clinical disease problem
where 2–3% of the elderly female population suffer from intermittent hand pain that affects
their general health. The condition is associated with a cut-off SUA level of�372 μmol/L rais-
ing questions of intervention in the form of uric acid lowering therapies. It is obvious that rep-
lication of the current findings is crucial as they could have extensive consequences with
regard to the treatment of hyperuricemia.
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